Johnson & Johnson, Mauna Kea launch study of lung cancer biopsy guidance tool
No longer will surgeons be flying blind while performing biopsies of peripheral lung nodules—at least, not if Mauna Kea Technologies and Johnson & Johnson’s Lung Cancer Initiative have anything to say about it.
